2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline

C147H98N12 — CID 164994147

IUPAC2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline
SMILESc1ccc(-c2cc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3nc4ccccc4nc3-c3ccccc3)c2)cc1
InChIInChI=1S/2C51H34N4.C45H30N4/c1-4-15-35(16-5-1)42-32-43(36-26-28-38(29-27-36)50-51(39-19-8-3-9-20-39)55-30-13-12-25-47(55)54-50)34-44(33-42)40-21-14-22-41(31-40)49-48(37-17-6-2-7-18-37)52-45-23-10-11-24-46(45)53-49;1-4-14-35(15-5-1)42-32-43(36-23-27-39(28-24-36)49-48(38-16-6-2-7-17-38)52-45-20-10-11-21-46(45)53-49)34-44(33-42)37-25-29-40(30-26-37)50-51(41-18-8-3-9-19-41)55-31-13-12-22-47(55)54-50;1-4-14-31(15-5-1)36-28-37(30-38(29-36)43-42(33-16-6-2-7-17-33)46-39-20-10-11-21-40(39)47-43)32-23-25-34(26-24-32)44-45(35-18-8-3-9-19-35)49-27-13-12-22-41(49)48-44/h2*1-34H;1-30H
InChIKeyHHOAKXZRRZEMGR-UHFFFAOYSA-N
MW2032.49 g/mol
LogP37.17
Rot. Bonds20

About 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline

2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline (PubChem CID 164994147) has the molecular formula C147H98N12 and a molecular weight of 2032.49 g/mol. Its IUPAC name is 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline.

Molecular Properties

Compound Name2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline
PubChem CID164994147
Molecular FormulaC147H98N12
Molecular Weight2032.49 g/mol
Exact Mass2030.80
IUPAC Name2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline
SMILESc1ccc(-c2cc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3nc4ccccc4nc3-c3ccccc3)c2)cc1
InChIInChI=1S/2C51H34N4.C45H30N4/c1-4-15-35(16-5-1)42-32-43(36-26-28-38(29-27-36)50-51(39-19-8-3-9-20-39)55-30-13-12-25-47(55)54-50)34-44(33-42)40-21-14-22-41(31-40)49-48(37-17-6-2-7-18-37)52-45-23-10-11-24-46(45)53-49;1-4-14-35(15-5-1)42-32-43(36-23-27-39(28-24-36)49-48(38-16-6-2-7-17-38)52-45-20-10-11-21-46(45)53-49)34-44(33-42)37-25-29-40(30-26-37)50-51(41-18-8-3-9-19-41)55-31-13-12-22-47(55)54-50;1-4-14-31(15-5-1)36-28-37(30-38(29-36)43-42(33-16-6-2-7-17-33)46-39-20-10-11-21-40(39)47-43)32-23-25-34(26-24-32)44-45(35-18-8-3-9-19-35)49-27-13-12-22-41(49)48-44/h2*1-34H;1-30H
InChIKeyHHOAKXZRRZEMGR-UHFFFAOYSA-N
XLogP37.17
TPSA129.24 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds20
Heavy Atoms159
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002032.49
LogP ≤ 537.17
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Analyze 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline?
The IUPAC name of 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline (CID 164994147) is 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline.
What is the SMILES notation for 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline?
The canonical SMILES for 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline is c1ccc(-c2cc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccc(-c4nc5ccccn5c4-c4ccccc4)cc3)cc(-c3nc4ccccc4nc3-c3ccccc3)c2)cc1.
What is the InChIKey of 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline?
The InChIKey is HHOAKXZRRZEMGR-UHFFFAOYSA-N. The full InChI is InChI=1S/2C51H34N4.C45H30N4/c1-4-15-35(16-5-1)42-32-43(36-26-28-38(29-27-36)50-51(39-19-8-3-9-20-39)55-30-13-12-25-47(55)54-50)34-44(33-42)40-21-14-22-41(31-40)49-48(37-17-6-2-7-18-37)52-45-23-10-11-24-46(45)53-49;1-4-14-35(15-5-1)42-32-43(36-23-27-39(28-24-36)49-48(38-16-6-2-7-17-38)52-45-20-10-11-21-46(45)53-49)34-44(33-42)37-25-29-40(30-26-37)50-51(41-18-8-3-9-19-41)55-31-13-12-22-47(55)54-50;1-4-14-31(15-5-1)36-28-37(30-38(29-36)43-42(33-16-6-2-7-17-33)46-39-20-10-11-21-40(39)47-43)32-23-25-34(26-24-32)44-45(35-18-8-3-9-19-35)49-27-13-12-22-41(49)48-44/h2*1-34H;1-30H.
What are the key properties of 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline?
2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline has a molecular weight of 2032.49 g/mol, XLogP of 37.17, 20 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline is sourced from PubChem (CID 164994147), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).